Development of Antiplasmodial Peptide–Drug Conjugates Using a Human Protein-Derived Cell-Penetrating Peptide with Selectivity for Infected Cells-Reference-Cited by-同舟云学术

Development of Antiplasmodial Peptide–Drug Conjugates Using a Human Protein-Derived Cell-Penetrating Peptide with Selectivity for Infected Cells

Published:2023-05-26 Issue:6 Volume:34 Page:1105-1113
ISSN:1043-1802
Container-title:Bioconjugate Chemistry
language:en
Short-container-title:Bioconjugate Chem.

Author:

Palombi Isabella R.¹²^ORCID,Lawrence Nicole³⁴,White Andrew M.¹²,Gare Caitlin L.¹²^ORCID,Craik David J.³⁴^ORCID,McMorran Brendan J.⁵,Malins Lara R.¹²^ORCID

Affiliation:

1. Research School of Chemistry, Australian National University, Canberra 2601, ACT, Australia

2. Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, Australian National University, Canberra 2601, ACT, Australia

3. Institute for Molecular Bioscience, The University of Queensland, Brisbane 4072, QLD, Australia

4. Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University of Queensland, Brisbane 4072, QLD, Australia

5. The John Curtin School of Medical Research, Australian National University, Canberra 2601, ACT, Australia

Funder

National Health and Medical Research Council

Australian Research Council

Australian Government

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Pharmaceutical Science,Pharmacology,Biomedical Engineering,Bioengineering,Biotechnology

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.bioconjchem.3c00147

Reference42 articles.